![]() |
市场调查报告书
商品编码
1954599
全球生物安全柜市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析、未来预测(2026-2034)Biological Safety Cabinet Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球生物安全柜 (BSC) 市场规模为 3.3008 亿美元,预计将从 2026 年的 3.4309 亿美元增长至 2034 年的 4.9626 亿美元,2026 年至 2034 年的复合年增长率 (CAGR) 为 4.70%。北美在 2025 年占市场主导地位,市占率达 38.46%。这主要得益于完善的实验室基础设施和日益活跃的研究活动。
生物安全柜是一种密封的通风实验室工作空间,旨在保护实验室人员、环境和样本免受生物危害和传染性物质的侵害。 由于慢性病和传染病的增加、製药业研发的扩展以及人们对实验室安全标准的日益重视,生物安全柜的重要性显着提升。
市场驱动因素
慢性病和传染病的增加
全球传染病数量的不断增加是主要的成长驱动因素。根据世界卫生组织的数据,到2025年,全球每年将有约300万至500万例严重的季节性流感病例。此外,美国疾病管制与预防中心 (CDC) 的统计数据显示,2023 年美国共有 9,633 例结核病病例,较 2022 年的 8,332 例呈上升趋势,反映出诊断需求的不断增长。
病患住院人数和诊断检测量的增加推动了医院和实验室对生物安全柜的需求。此外,製药和生技公司研发管线的扩展也进一步推动了生物安全柜的普及。
研发活动的扩展
到 2025 年,美国将有约 5,000 家製药公司运营,对受控、无污染实验室环境的需求持续增长。政府资助和生物安全措施的推广也在加速产品的应用。
市场限制因子
设备成本高
生物安全柜成本高是主要限制因素之一。根据2024年的行业数据,价格依配置不同,介于6,000美元至15,000美元之间。高级HEPA过滤器、紫外线系统、法规合规要求(美国NSF/ANSI 49标准,欧洲EN 12469标准)以及能耗都会显着增加拥有成本。
监理与营运挑战
严格的合规要求、频繁的审核、认证续期以及过滤器和紫外线灯等组件的供应链限制,都构成了障碍,尤其对于中小製造商和新兴市场而言。
市场机会
由于医疗基础设施的不断完善和研发投入的增加,巴西、墨西哥、中国和印度等新兴经济体预计将拥有巨大的成长潜力。政府为加强病原体研究设施和生物安全措施而采取的措施正在创造新的需求。
例如,巴西于2024年7月开始建造生物安全4级(BSL-4)实验室,反映出该地区对传染病研究日益增长的兴趣。
市场趋势
技术进步
先进感测器、人工智慧驱动的预测性维护、自动化合规性监控以及改进的生物安全柜性能的整合正在改变传统的生物安全柜。模组化设计和增强的使用者介面正变得越来越普遍。
2025年5月,赛默飞世尔科技发表了1500系列II级A2型生物安全柜,进一步丰富了其产品组合。同样,LabConco 在 2024 年 8 月发布了重新设计的 Logic 生物安全柜。
依类型
市场依类型分为 I 级、II 级和 III 级生物安全柜。由于 II 级生物安全柜能够全面保护人员、产品和环境,因此在 2026 年,II 级生物安全柜占主导地位,市场占有率高达 88.95%。
随着实验室安全措施日益严格,预计 I 级生物安全柜将稳定成长。
依最终使用者
在研发活动不断扩大和药物开发计划日益增多的推动下,预计生物技术和製药公司将在 2026 年占 39.72% 的市场占有率。医院、临床实验室和学术研究机构也是重要的需求来源。
北美
预计北美将在2025年以1.2696亿美元的市场规模引领市场,并在2026年扩大至1.3243亿美元。强劲的医疗保健支出(2023年美国人均医疗保健支出为14,570美元)和先进的实验室基础设施支撑了该地区的市场主导地位。光是美国市场预计在2026年就将达到1.1786亿美元。
欧洲
在监管认证和研究设施扩张的推动下,欧洲市场预计将保持稳定成长。预计2026年,英国市场规模将达到2,475万美元,德国市场规模将达2,858万美元。
亚太地区
预计亚太地区将显着成长。到2026年,随着医疗保健投资的增加和宣传活动的开展,预计中国市场规模将达到1,942万美元,日本将达到1,169万美元,印度将达到697万美元。
拉丁美洲、中东和非洲
这些地区正在增加对医疗保健基础设施的投资,并加强生物安全措施,从而支持市场稳步扩张。
The global biological safety cabinet (BSC) market was valued at USD 330.08 million in 2025 and is projected to grow from USD 343.09 million in 2026 to USD 496.26 million by 2034, registering a CAGR of 4.70% during 2026-2034. North America dominated the market in 2025, accounting for a 38.46% share, driven by strong laboratory infrastructure and increasing research activities.
Biological safety cabinets are enclosed, ventilated laboratory workspaces designed to protect laboratory personnel, the environment, and samples from biohazards and infectious agents. Their importance has grown significantly due to the rising burden of chronic and infectious diseases, expanding pharmaceutical R&D, and heightened awareness regarding laboratory safety standards.
Market Drivers
Rising Prevalence of Chronic and Infectious Diseases
The growing number of infectious diseases globally is a key growth driver. According to 2025 WHO data, approximately 3.0-5.0 million severe seasonal influenza cases occur annually worldwide. Additionally, CDC statistics reported 9,633 tuberculosis cases in 2023 in the U.S., compared to 8,332 in 2022, reflecting rising diagnostic needs.
Increasing patient admissions and diagnostic testing volumes have strengthened demand for biosafety cabinets across hospitals and laboratories. Furthermore, pharmaceutical and biotechnology companies are expanding R&D pipelines, further boosting adoption.
Growing Research & Development Activities
With around 5,000 pharmaceutical companies operating in the U.S. in 2025, the need for controlled and contamination-free laboratory environments continues to rise. Government funding and biosecurity preparedness initiatives are also accelerating product penetration.
Market Restraints
High Cost of Devices
One of the primary limiting factors is the high cost of biosafety cabinets. According to 2024 industry data, prices range between USD 6,000 and USD 15,000 depending on configuration. Advanced HEPA filtration, UV systems, regulatory compliance requirements (NSF/ANSI 49 in the U.S., EN 12469 in Europe), and energy consumption significantly increase ownership costs.
Regulatory and Operational Challenges
Stringent compliance requirements, frequent audits, certification updates, and supply chain constraints for components such as filters and UV lamps create barriers, particularly for smaller manufacturers and emerging markets.
Market Opportunities
Emerging nations such as Brazil, Mexico, China, and India present significant growth potential due to expanding healthcare infrastructure and increasing R&D investments. Government initiatives to strengthen pathogen research laboratories and biosafety preparedness are creating new demand avenues.
For instance, Brazil initiated construction of a Biosafety Level 4 (BSL-4) laboratory in July 2024, reflecting growing regional focus on infectious disease research.
Market Trends
Technological Advancements
The integration of advanced sensors, AI-enabled predictive maintenance, automated compliance monitoring, and improved containment features is transforming traditional biosafety cabinets. Modular designs and enhanced user interfaces are gaining popularity.
In May 2025, Thermo Fisher Scientific launched the 1500 Series Class II Type A2 BSC, strengthening its product portfolio. Similarly, in August 2024, Labconco introduced a redesigned Logic Biosafety Cabinet.
By Type
The market is segmented into Class I, Class II, and Class III cabinets. The Class II segment dominated in 2026 with an 88.95% market share, owing to its comprehensive protection capabilities for personnel, products, and the environment.
Class I cabinets are projected to grow steadily due to rising lab safety initiatives.
By End User
The biotechnology and pharmaceutical companies segment held a 39.72% share in 2026, driven by expanding R&D activities and increasing drug development initiatives. Hospitals & clinical laboratories and academic research institutes also contribute significantly to demand.
North America
North America led the market with a value of USD 126.96 million in 2025, increasing to USD 132.43 million in 2026. Strong healthcare spending (U.S. per capita healthcare expenditure of USD 14,570 in 2023) and advanced laboratory infrastructure support regional dominance. The U.S. market alone is projected to reach USD 117.86 million in 2026.
Europe
Europe is expected to grow steadily, supported by regulatory certifications and expanding research labs. The UK market is projected at USD 24.75 million in 2026, while Germany is expected to reach USD 28.58 million in 2026.
Asia Pacific
Asia Pacific is anticipated to register considerable growth. By 2026, China is projected to reach USD 19.42 million, Japan USD 11.69 million, and India USD 6.97 million, driven by expanding healthcare investments and awareness initiatives.
Latin America & Middle East & Africa
These regions are witnessing growing healthcare infrastructure investments and biosafety initiatives, supporting steady market expansion.
Competitive Landscape
Key players include Thermo Fisher Scientific Inc., Haier Biomedical, Esco Micro Pte. Ltd., Labconco, Kewaunee International Group, Baker Co., Germfree, and Biobase Biodusty. Companies are focusing on acquisitions, certifications, and innovative launches to expand global presence.
For example:
Conclusion
The global biological safety cabinet market demonstrates stable growth, increasing from USD 330.08 million in 2025 to USD 343.09 million in 2026, and projected to reach USD 496.26 million by 2034, growing at a 4.70% CAGR. Rising infectious disease prevalence, expanding pharmaceutical R&D, and technological advancements are key growth drivers. Although high costs and regulatory complexities present challenges, strong government funding, emerging market expansion, and innovation in AI-integrated biosafety systems are expected to sustain long-term market growth through 2034.
Segmentation By Type
By End User
By Geography